Carcinogenesis Testing

Assess carcinogenic potential of personal care ingredients — cell transformation, tumor promotion markers, and epigenetic modification endpoints.

Browse Products Back to Personal Care

Carcinogenic Risk Assessment for Personal Care

Evaluating the carcinogenic potential of cosmetic ingredients is essential for consumer safety, particularly for products applied repeatedly over long periods. Enzo Life Sciences provides in vitro tools for assessing key hallmarks of carcinogenesis including cell transformation, uncontrolled proliferation, apoptosis resistance, epigenetic modifications, and tumor promotion. These assays support a weight-of-evidence approach to carcinogenicity assessment without relying on traditional two-year rodent bioassays.

Cell Transformation Assays

Reagents and detection kits supporting the Bhas 42 cell transformation assay and other in vitro transformation systems. Detect morphological transformation, focus formation, and anchorage-independent growth — hallmarks of carcinogenic transformation.

CTA

View Products

Proliferation & Cell Cycle

BrdU incorporation kits, Ki-67 detection, and cell cycle analysis reagents for evaluating uncontrolled cell proliferation. Quantify the growth-stimulatory effects of test substances on normal and pre-neoplastic cell populations.

Proliferation

View Products

Apoptosis Resistance

Multi-parameter apoptosis assessment including caspase activity, Bcl-2/Bax ratio measurement, cytochrome c release, and Annexin V/PI staining. Detect resistance to programmed cell death — a key feature of carcinogenic transformation.

Apoptosis

View Products

Epigenetic Modification

ELISA kits for global DNA methylation (5-mC), hydroxymethylation (5-hmC), and histone modification (H3K9me3, H3K27me3, H3K4me3). Evaluate epigenetic changes induced by cosmetic ingredients that may contribute to carcinogenic risk.

Epigenetics

View Products